Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-21-076475
Filing Date
2021-06-03
Accepted
2021-06-03 17:30:33
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2039434-11_s1a.htm S-1/A 2605938
2 EXHIBIT 23.1 tm2039434d15_ex23-1.htm EX-23.1 2796
3 EXHIBIT 23.6 tm2039434d15_ex23-6.htm EX-23.6 3078
4 GRAPHIC lg_alzamendneuro-4clr.jpg GRAPHIC 47608
5 GRAPHIC tm2039434d8-cov_ifc4clr.jpg GRAPHIC 4227073
6 GRAPHIC tm2039434d8-tbl_develop4clr.jpg GRAPHIC 141774
7 GRAPHIC tm2039434d8-pht_alzhei4clr.jpg GRAPHIC 368812
8 GRAPHIC tm2039434d8-tbl_patents4clr.jpg GRAPHIC 164857
  Complete submission text file 0001104659-21-076475.txt   9428873
Mailing Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612
Business Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-1/A | Act: 33 | File No.: 333-255955 | Film No.: 21993737
SIC: 2834 Pharmaceutical Preparations